Ameritox

Baltimore, United States Founded: 1996 • Age: 30 yrs Acquired By Aegis Science
Pain medication monitoring solutions are provided for US clinicians.

About Ameritox

Ameritox is a Healthcare company based in Baltimore (United States) founded in 1996, and was acquired by Aegis Science in March 2018. Pain medication monitoring solutions are provided for US clinicians. Ameritox has completed 1 acquisition, including PRIUM. Its chief executive, as recorded, is A. Scott Walton. Ameritox offers products and services including CBD Oil Guides, Drug Testing Articles, and Cannabis Strain Reviews. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include MedAware, IntegenX and Precision Diagnostics; 2 of its 3 listed competitors have raised funding.

Company details

Ameritox (Formerly known as Universal Toxicology Laboratories) develops pain medication monitoring solutions for behavioral health clinicians in the United States necessary to address the national epidemic of prescription drug misuse, abuse and diversion. It offers laboratory services and practice management tools; Rx GuardianCD, a urine drug monitoring solution that helps clinicians to identify potential abuse, misuse, or diversion of patient medication; Rx Guardian INSIGHT Report, which provides physicians with a view of their chronic pain patients medication monitoring results; and Rx Guardian results report that provides information available on patients pain medication use in easy-to-read format. The company also provides clinical staff training and support, results interpretation and support, contract and payer partnerships, billing and reimbursement, and practice management resources.

Key Metrics

Products & Services of Ameritox

Ameritox offers a comprehensive portfolio of products and services, including CBD Oil Guides, Drug Testing Articles, and Cannabis Strain Reviews.

CBD Oil Guides
Educational Content

Resources on selecting and using CBD oil for health benefits.

Drug Testing Articles
Informational Service

Articles explaining drug test processes and marijuana detection methods.

Cannabis Strain Reviews
Review Content

Guides reviewing various cannabis strains and their effects.

Funding Insights of Ameritox

  • Total Rounds 3
  • Last Round Debt – Venture β€” $175M
  • First Round $35M

    (Jan 2007)

  • Investors Count 6

All 3 funding rounds of Ameritox with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2015$175MDebt – Venture––
Nov 2007Private Equity Round––
Jan 2007$35MDebt – Conventional––
Valuation history

7 investors in total: 7 institutional.

Investors in Ameritox

Ameritox has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Aegis Science, NewStar Financial and Fifth Street Asset Management.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private debt funds are managed for credit investing strategies.
2007fifthstreetfinance.comWhite Plains, United States
Private equity firm
sterlingpartners.comChicago, United States
Sequoia Capital is engaged in venture capital investments.
1972sequoiacap.com
Venture capital fund focused on investing in multiple sectors
baincapitalventures.comBoston, United States
Financial services are provided by NewStar Financial in Boston.
2004newstarfin.comBoston, United States
Financial services in capital markets are provided by BMO.
capitalmarkets.bmo.com
Drug testing and clinical laboratory services are provided.
1986aegislabs.comNashville, United States
Premium access

Investor details for Ameritox

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ameritox

1 people are tracked at Ameritox (1 in leadership).

NameRoleGroup
A. Scott Walton
CEOLeadership
Premium access

Complete people profiles for Ameritox

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ameritox

Ameritox has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PRIUM.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Chronic pain intervention programs are provided to patients by PRIUM.
prium.comDuluth, United States1987Aug 2013β€’β€’β€’β€’
Premium access

Complete acquisition details for Ameritox

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Ameritox

5 dated milestones of Ameritox across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ameritox is founded.
  2. Funding First funding round of $35.0M.
  3. Acquisition Acquires PRIUM.
  4. Funding Latest funding round, Debt – Venture, of $175.0M.
  5. Exit Acquired by Aegis Science.

Competitors of Ameritox

Ameritox has 3 listed competitors in our database, 2 of them funded. They include MedAware, IntegenX and Precision Diagnostics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medaware.com2012Stamford, United States$9M
Provider of an AI based medication dosage and safety managing software for healthcare professionals
integenx.com2006Pleasanton, United States$92.06M78
Instruments for rapid human DNA identification are developed.
precisiondxlab.com2011San Diego, United States358
Quantitative urine drug testing is provided for patient monitoring.
Premium access

Detailed competitors of Ameritox

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ameritox

Websites that share an audience with Ameritox (ameritox.com).

Similar websites

Websites whose visitors overlap most with Ameritox. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
amicusrx.com
100%
20.4K#1,355,769View details
aleretoxicology.com
94%
1.9K#6,627,628View details
nmslabs.com
92%
#1,525,649View details
usscreeningsource.com
usscreeningsource.com
89%
#10,006,909–
en.wikipedia.org
en.wikipedia.org
58%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Ameritox

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Ameritox (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ameritox

Premium access

Complete news archive for Ameritox

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ameritox

Ameritox was founded in 1996 and raised its 1st funding round 11 years after it was founded.

Ameritox is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.

A. Scott Walton is the CEO of Ameritox, as recorded in our data.

Ameritox (Formerly known as Universal Toxicology Laboratories) develops pain medication monitoring solutions for behavioral health clinicians in the United States necessary to address the national epidemic of prescription drug misuse, abuse and diversion. It offers laboratory services and practice management tools; Rx GuardianCD, a urine drug monitoring solution that helps clinicians to identify potential abuse, misuse, or diversion of patient medication; Rx Guardian INSIGHT Report, which provides physicians with a view of their chronic pain patients medication monitoring results; and Rx Guardian results report that provides information available on patients pain medication use in easy-to-read format. The company also provides clinical staff training and support, results interpretation and support, contract and payer partnerships, billing and reimbursement, and practice management resources.

Ameritox's top competitors include IntegenX, Precision Diagnostics and MedAware.

Ameritox offers CBD Oil Guides, Drug Testing Articles, and Cannabis Strain Reviews.

Ameritox has made 1 acquisition, including PRIUM.

Ameritox has 7 investors. Key investors include Aegis Science, NewStar Financial, Fifth Street Asset Management, Sterling Partners, and Sequoia Capital.

Yes. Ameritox was acquired by Aegis Science in March 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available